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addressing the regulation of functional
foods. 'Functional foods' is a concept that
everyone knows aboutbutforwhich there is
no official policy. The FDA must face the
issues raised bythese products to ensure that
functional foods become a public health
boon rather than the snake oil of the 21st
century.
Estrogen's a Natural in Herbal
Remedies
Patricia Eagon, an associate professor of
medicine at Pennsylvania's University of
Pittsburgh, decided to consult an herbalist
after she began to suspect that Premarin, the
prescription estrogen she was taking for
menopausal symptoms, was causing a rash
on her leg. The herbalist, whom she had
consulted before on other health matters,
gave her a mixture of several herbs to take
instead of Premarin. The concoction both
relieved Eagon's hot flashes and
piqued her curiosity about how the
herbal ingredientsworked.
Eagon decided to launch her own
experiment to find out. She conduct-
ed an estrogen-binding assay on 15
herbs commonly used in treating
menopause, including 3 from the
remedy she had taken herself. Herbs
that showed estrogenic activity in the
screening were then fed to rats that
had undergone ovariectomy. To test
the herbs' estrogenicity, Eagon
weighed the rats' uteri at the end of
the study and measured changes in
the concentration ofluteinizing hor-
mone in their blood (enlarged uterus
and decreased luteinizing hormone
concentration are both indicators of
estrogenic activity). The tests indicated an
estrogenic effect in four of the herbs-
chaste tree berry (Vitex agnus-castus), dong
quai (Angelica sinensis), American ginseng
(Panax quinquefolium), and black cohosh
(Cimicifuga racemosa). Eagon reported her
findings on 11 April 1999 at the annual
meeting of the American Association for
Cancer Research and is currently preparing
the results for publication.
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Herbal estrogens. A recent study by associate professor of medicine
Patricia Eagon suggests that some herbs may have powerful estrogenic
properties.
Eagon's findings have implications for
the fast-growing number ofpeople who are
embracing alternative medicine. According
to the U.S. Food and Drug Administration
(FDA), more than halfofall U.S. adults use
over-the-counter vitamins, dietary supple-
ments, or herbal remedies. Ann Fonfa,
founder ofthe New York City-based Annie
Appleseed Project to promote the study of
alternative cancer treatments, estimates
(based on national averages for the general
population) that 30% of menopausal
women treat themselves with medicinal
herbs, many because they believe such herbs
are safer and gentler than prescription
drugs. Yet they have no proofofthe herbs'
medicinal value and safety beyond the folk
wisdom ofherbalists; unlike pharmaceutical
manufacturers, manufacturers of herbal
remedies are not required by the FDA to
prove their products' safetyand efficacy.
Eagon's discovery ofestrogenicity in the
herbs she tested comes as no surprise to
some researchers. "While the specific find-
ings are new, there is well-known, well-
described estrogenic activity in plants," says
Daniel Sheehan, director of the Endocrine
Disruptor Knowledge Base Program of the
FDA's National Center for Toxicology
Research in Jefferson, Arkansas. He points
to the example ofsubterranean clover, a type
of clover that farmers have known for 50
years to cause reproductive failure in sheep.
While Eagon's research may help
explain why certain herbs may relieve hot
flashes and other menopausal symptoms, it
raises several more questions. Ofkey inter-
est is how these phytoestrogens react in the
body. "We really need to measure these
things inwomen," Eagon says.
Premarin has long been doctors' drug of
choice in treating menopause because it not
only relieves symptoms but also helps pre-
vent osteoporosis and heart disease.
However, the synthetic hormone also ele-
vates women's risk of breast and uterine
cancer, which scares many would-be users
away.
Because of the estrogenic activity she
observed in the herbs she studied, Eagon
feels compelled to warn women at high risk
of breast or uterine cancer against taking
them, as estrogen has been implicated in
some forms of cancer. Yet she admits she
doesn't know if the herbs promote cancer.
In fact, she says, "We may test these further
and find they inhibit cancer. It looks as if
soy has a positive effect in preventing breast
cancer. These herbs may also be able to pre-
vent it."
Eagon also doesn't know if estrogenic
herbs give women the same protection
against heart disease and osteoporosis that
synthetic estrogen does. "One question is,
how do estrogenic substances from plants
compare in activity with pharmaceutical
estrogens," says Fredi Kronenberg, director
ofthe Rosenthal Center for Complementary
and Alternative Medicine at Columbia
University College of Physicians and
Surgeons in New York City. "Do they have
a broadspectrum ofestrogenic activityor are
they more selective in action? We don't have
theansweryet.`
Some ofthose answers may come out of
Eagon's upcoming research. She first plans
to investigate whether the herbs inhibit or
promote breast cancer by feeding them to
rats with a genetic susceptibility to the dis-
ease. Eagon also plans to delve into the
herbs' effects on premenopausal
women. Younger women take
chaste tree berry and dong quai
for premenstrual syndrome,
amenorrhea, and infertility;
American ginseng is recommend-
ed for stomach upset, lack of
appetite, physical exhaustion,
and infection. Eagon would use
mice with intact ovaries to simu-
late the impact on pre-
menopausal women.
"People think [taking herbal
remedies] is like eating another
serving of broccoli," Eagon says.
"These things are not all benign.
The more we know about them,
the better offwe'll be."
Harvesting Monoclonal
Antibodies from Plants
When monoclonal antibodies were first
developed 20 years ago, they were hyped as
a magic bullet for curing cancer and other
diseases. However, killing cancer cells with
these immune proteins, which are artificially
produced and which neutralize one specific
antigen or foreign protein, was not as
straightforward as first assumed, and clinical
failures occurred. Moreover, the high costof
producing monoclonal antibodies by tradi-
tional cell fermentation methods limited
their applications. These setbacks have
forced scientists to look more realistically at
monoclonal antibodies.
Now, researchers at EPIcyte Pharma-
ceutical, based in San Diego, California,
hope to revitalize interest in monoclonal
antibodies with a new technology that pro-
duces large supplies ofthe proteins inexpen-
sively. Their new technology uses green
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